10-Q 1 met-2018930x10q.htm 10-Q Document
 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 ______________________________________
Form 10-Q
(Mark One)
þ
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2018
or
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
Commission file number: 001-15787
 ________________________________________
MetLife, Inc.
(Exact name of registrant as specified in its charter)
Delaware
 
13-4075851
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
200 Park Avenue, New York, N.Y.
 
10166-0188
(Address of principal executive offices)
 
(Zip Code)
(212) 578-9500
(Registrant’s telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
þ
Accelerated filer
¨
Non-accelerated filer
¨

Smaller reporting company
¨

 
 
Emerging growth company
¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨No þ
At October 31, 2018, 986,838,252 shares of the registrant’s common stock, $0.01 par value per share, were outstanding.
 
 



Table of Contents
 
 
Page
 
Item 1.
Financial Statements (Unaudited) (at September 30, 2018 and December 31, 2017 and for the Three Months and Nine Months Ended September 30, 2018 and 2017)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
Item 3.
Item 4.
 
 
 
 
Item 1.
Item 1A.
Item 2.
Item 6.
 
 
 
 
 
 
 
 
 



As used in this Form 10Q, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates.
Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10‑Q, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. These statements can be identified by the fact that they do not relate strictly to historical or current facts. They use words and terms such as “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “believe,” “will,” and other words and terms of similar meaning, or are tied to future periods, in connection with a discussion of future performance. In particular, these include statements relating to future actions, prospective services or products, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, trends in operations and financial results.
Many factors will be important in determining the results of MetLife, Inc., its subsidiaries and affiliates. Forward-looking statements are based on our assumptions and current expectations, which may be inaccurate, and on the current economic environment, which may change. These statements are not guarantees of future performance. They involve a number of risks and uncertainties that are difficult to predict. Results could differ materially from those expressed or implied in the forward-looking statements. Risks, uncertainties, and other factors that might cause such differences include the risks, uncertainties and other factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission. These factors include: (1) adverse effects which may arise in connection with the material weaknesses in our internal control over financial reporting or our failure to promptly remediate them; (2) difficult conditions in the global capital markets; (3) increased volatility and disruption of the global capital and credit markets, which may affect our ability to meet liquidity needs and access capital, including through our credit facilities, generate fee income and market-related revenue and finance statutory reserve requirements and may require us to pledge collateral or make payments related to declines in value of specified assets, including assets supporting risks ceded to certain of our captive reinsurers or hedging arrangements associated with those risks; (4) exposure to global financial and capital market risks, including as a result of the United Kingdom’s notice of withdrawal from the European Union or other disruption in global political, security or economic conditions; (5) impact on us of comprehensive financial services regulation reform; (6) numerous rulemaking initiatives required or permitted by the Dodd-Frank Wall Street Reform and Consumer Protection Act which may impact how we conduct our business, including those compelling the liquidation of certain financial institutions; (7) regulatory, legislative or tax changes relating to our insurance, international, or other operations that may affect the cost of, or demand for, our products or services, or increase the cost or administrative burdens of providing benefits to employees; (8) adverse results or other consequences from litigation, arbitration or regulatory investigations; (9) potential liquidity and other risks resulting from our participation in a securities lending program and other transactions; (10) investment losses and defaults, and changes to investment valuations; (11) changes in assumptions related to investment valuations, deferred policy acquisition costs, deferred sales inducements, value of business acquired or goodwill; (12) impairments of goodwill and realized losses or market value impairments to illiquid assets; (13) defaults on our mortgage loans; (14) the defaults or deteriorating credit of other financial institutions that could adversely affect us; (15) economic, political, legal, currency and other risks relating to our international operations, including with respect to fluctuations of exchange rates; (16) downgrades in our claims paying ability, financial strength or credit ratings; (17) a deterioration in the experience of the closed block established in connection with the reorganization of Metropolitan Life Insurance Company; (18) availability and effectiveness of reinsurance, hedging or indemnification arrangements, as well as any default or failure of counterparties to perform; (19) differences between actual claims experience and underwriting and reserving assumptions; (20) ineffectiveness of risk management policies and procedures; (21) catastrophe losses; (22) increasing cost and limited market capacity for statutory life insurance reserve financings; (23) heightened competition, including with respect to pricing, entry of new competitors, consolidation of distributors, the development of new products by new and existing competitors, and for personnel; (24) exposure to losses related to variable annuity guarantee benefits, including from significant and sustained downturns or extreme volatility in equity markets, reduced interest rates, unanticipated policyholder behavior, mortality or longevity, and any adjustment for nonperformance risk; (25) our ability to address difficulties, unforeseen liabilities, asset impairments, or rating agency actions arising from (a) business acquisitions and integrating and managing the growth of such acquired businesses, (b) dispositions of businesses via sale, initial public offering, spin-off or otherwise, including failure to achieve projected operational benefits from such transactions and any restrictions, liabilities, losses or indemnification obligations arising from any transitional services or tax arrangements related to the separation of any business, or from the failure of such a separation to qualify for any intended tax-free treatment, (c) entry into joint ventures, or (d) legal entity reorganizations; (26) unanticipated or adverse developments that could adversely affect our achieving expected operational or other benefits from the separation of Brighthouse Financial, Inc. and its subsidiaries (“Brighthouse”); (27) liabilities, losses or indemnification obligations arising from our transitional services, investment management or tax arrangements or other agreements with Brighthouse; (28) failure of the separation of Brighthouse to qualify for intended tax-free treatment; (29) legal, regulatory and other restrictions affecting MetLife, Inc.’s ability to pay dividends and repurchase common stock; (30) MetLife, Inc.’s and its subsidiary holding companies’ primary reliance, as holding companies, on dividends from subsidiaries to meet free cash flow targets and debt payment obligations and the applicable regulatory restrictions on the ability of the subsidiaries to pay such dividends; (31) the possibility that MetLife, Inc.’s Board of Directors may influence the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; (32) changes in accounting standards, practices and/or policies; (33) increased expenses relating to pension and postretirement benefit plans, as well as health care and other employee benefits; (34) inability to protect our intellectual property rights or claims of infringement of the intellectual property rights of others; (35) difficulties in marketing and distributing products through our distribution channels; (36) provisions of laws and our incorporation documents that may delay, deter or prevent takeovers and corporate combinations involving MetLife; (37) the effects of business disruption or economic contraction due to disasters such as terrorist attacks, cyberattacks, other hostilities, or natural catastrophes, including any related impact on the value of our investment portfolio, our disaster recovery systems, cyber- or other information security systems and management continuity planning; (38) any failure to protect the confidentiality of client information; (39) the effectiveness of our programs and practices in avoiding giving our associates incentives to take excessive risks; (40) the impact of technological changes on our businesses; and (41) other risks and uncertainties described from time to time in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission.
MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in reports to the U.S. Securities and Exchange Commission.
Corporate Information
We announce financial and other information about MetLife to our investors through the MetLife Investor Relations web page at www.metlife.com, as well as U.S. Securities and Exchange Commission filings, news releases, public conference calls and webcasts. MetLife encourages investors to visit the Investor Relations web page from time to time, as information is updated and new information is posted. The information found on our website is not incorporated by reference into this Quarterly Report on Form 10-Q or in any other report or document we file with the U.S. Securities and Exchange Commission, and any references to our website are intended to be inactive textual references only.
Note Regarding Reliance on Statements in Our Contracts
See “Exhibits — Note Regarding Reliance on Statements in Our Contracts” for information regarding agreements included as exhibits to this Quarterly Report on Form 10-Q.

2


Part I — Financial Information
Item 1. Financial Statements
MetLife, Inc.
Interim Condensed Consolidated Balance Sheets
September 30, 2018 and December 31, 2017 (Unaudited)
(In millions, except share and per share data)
 
 
September 30, 2018
 
December 31, 2017
Assets
 
 
 
 
Investments:
 
 
 
 
Fixed maturity securities available-for-sale, at estimated fair value (amortized cost: $293,268 and $286,069, respectively)
 
$
304,840

 
$
308,931

Equity securities, at estimated fair value
 
1,479

 
2,513

Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes $5 and $6, respectively, relating to variable interest entities)
 
13,540

 
16,745

Mortgage loans (net of valuation allowances of $336 and $314, respectively; includes $323 and $520, respectively, under the fair value option)
 
72,461

 
68,731

Policy loans
 
9,703

 
9,669

Real estate and real estate joint ventures (includes $631 and $25, respectively, of real estate held-for-sale)
 
9,977

 
9,637

Other limited partnership interests
 
6,374

 
5,708

Short-term investments, principally at estimated fair value
 
5,231

 
4,870

Other invested assets (includes $128 and $125, respectively, relating to variable interest entities)
 
16,336

 
17,263

Total investments
 
439,941

 
444,067

Cash and cash equivalents, principally at estimated fair value (includes $10 and $12, respectively, relating to variable interest entities)
 
12,490

 
12,701

Accrued investment income
 
3,691

 
3,524

Premiums, reinsurance and other receivables (includes $3 and $3, respectively, relating to variable interest entities)
 
19,820

 
18,423

Deferred policy acquisition costs and value of business acquired
 
19,160

 
18,419

Goodwill
 
9,440

 
9,590

Other assets (includes $2 and $2, respectively, relating to variable interest entities)
 
8,493

 
8,167

Separate account assets
 
185,416

 
205,001

Total assets
 
$
698,451

 
$
719,892

Liabilities and Equity
 
 
 
 
Liabilities
 
 
 
 
Future policy benefits
 
$
185,476

 
$
177,974

Policyholder account balances
 
184,094

 
182,518

Other policy-related balances
 
16,207

 
15,515

Policyholder dividends payable
 
709

 
682

Policyholder dividend obligation
 
456

 
2,121

Payables for collateral under securities loaned and other transactions
 
26,075

 
25,723

Short-term debt
 
290

 
477

Long-term debt (includes $5 and $6, respectively, at estimated fair value, relating to variable interest entities)
 
13,408

 
15,686

Collateral financing arrangement
 
1,073

 
1,121

Junior subordinated debt securities
 
3,146

 
3,144

Current income tax payable
 
166

 
311

Deferred income tax liability
 
4,924

 
6,767

Other liabilities (includes $1 and $3, respectively, relating to variable interest entities)
 
25,202

 
23,982

Separate account liabilities
 
185,416

 
205,001

Total liabilities
 
646,642

 
661,022

Contingencies, Commitments and Guarantees (Note 15)
 

 

Equity
 
 
 
 
MetLife, Inc.’s stockholders’ equity:
 
 
 
 
Preferred stock, par value $0.01 per share; $3,405 and $2,100 aggregate liquidation preference, respectively
 

 

Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,171,428,557 and 1,168,710,101 shares issued, respectively; 986,644,069 and 1,043,588,396 shares outstanding, respectively
 
12

 
12

Additional paid-in capital
 
32,475

 
31,111

Retained earnings
 
27,331

 
26,527

Treasury stock, at cost; 184,784,488 and 125,121,705 shares, respectively
 
(9,193
)
 
(6,401
)
Accumulated other comprehensive income (loss)
 
1,000

 
7,427

Total MetLife, Inc.’s stockholders’ equity
 
51,625

 
58,676

Noncontrolling interests
 
184

 
194

Total equity
 
51,809

 
58,870

Total liabilities and equity
 
$
698,451

 
$
719,892

See accompanying notes to the interim condensed consolidated financial statements.

3

MetLife, Inc.
Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
For the Three Months and Nine Months Ended September 30, 2018 and 2017 (Unaudited)
(In millions, except per share data)

 
 
Three Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
 
2018
 
2017
 
2018
 
2017
Revenues
 
 
 
 
 
 
 
 
Premiums
 
$
10,242

 
$
10,876

 
$
34,573

 
$
29,421

Universal life and investment-type product policy fees
 
1,343

 
1,428

 
4,105

 
4,152

Net investment income
 
4,486

 
4,295

 
12,704

 
12,909

Other revenues
 
479

 
301

 
1,428

 
935

Net investment gains (losses)
 
117

 
(606
)
 
(443
)
 
(414
)
Net derivative gains (losses)
 
(378
)
 
(123
)
 
(88
)
 
(535
)
Total revenues
 
16,289

 
16,171

 
52,279

 
46,468

Expenses
 
 
 
 
 
 
 
 
Policyholder benefits and claims
 
10,080

 
10,728

 
33,664

 
29,018

Interest credited to policyholder account balances
 
1,334

 
1,338

 
3,527

 
4,081

Policyholder dividends
 
327

 
302

 
933

 
925

Other expenses
 
3,469

 
3,318

 
10,319

 
9,869

Total expenses
 
15,210

 
15,686

 
48,443

 
43,893

Income (loss) from continuing operations before provision for income tax
 
1,079

 
485

 
3,836

 
2,575

Provision for income tax expense (benefit)
 
164

 
(398
)
 
770

 
(116
)
Income (loss) from continuing operations, net of income tax
 
915

 
883

 
3,066

 
2,691

Income (loss) from discontinued operations, net of income tax
 

 
(968
)
 

 
(986
)
Net income (loss)
 
915

 
(85
)
 
3,066

 
1,705

Less: Net income (loss) attributable to noncontrolling interests
 
3

 
6

 
10

 
12

Net income (loss) attributable to MetLife, Inc.
 
912

 
(91
)
 
3,056

 
1,693

Less: Preferred stock dividends
 
32

 
6

 
84

 
58

Net income (loss) available to MetLife, Inc.’s common shareholders
 
$
880

 
$
(97
)
 
$
2,972

 
$
1,635

Comprehensive income (loss)
 
$
(940
)
 
$
(192
)
 
$
(4,273
)
 
$
4,668

Less: Comprehensive income (loss) attributable to noncontrolling interests, net of income tax
 
2

 
10

 
10

 
16

Comprehensive income (loss) attributable to MetLife, Inc.
 
$
(942
)
 
$
(202
)
 
$
(4,283
)
 
$
4,652

Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders:
 
 
 
 
 
 
 
 
Basic
 
$
0.89

 
$
0.82

 
$
2.93

 
$
2.44

Diluted
 
$
0.88

 
$
0.81

 
$
2.91

 
$
2.42

Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
 
 
 
 
 
 
 
 
Basic
 
$
0.89

 
$
(0.09
)
 
$
2.93

 
$
1.52

Diluted
 
$
0.88

 
$
(0.09
)
 
$
2.91

 
$
1.51

See accompanying notes to the interim condensed consolidated financial statements.


4


MetLife, Inc.
Interim Condensed Consolidated Statements of Equity
For the Nine Months Ended September 30, 2018 and 2017 (Unaudited)
(In millions)
 
 
Preferred
Stock
 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Treasury
Stock
at Cost
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
MetLife, Inc.’s
Stockholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
Balance at December 31, 2017
 
$

 
$
12

 
$
31,111

 
$
26,527

 
$
(6,401
)
 
$
7,427

 
$
58,676

 
$
194

 
$
58,870

Cumulative effects of changes in accounting principles, net of income tax (Note 1)
 
 
 
 
 
 
 
(905
)
 
 
 
912

 
7

 
 
 
7

Balance at January 1, 2018
 

 
12

 
31,111

 
25,622

 
(6,401
)
 
8,339

 
58,683

 
194

 
58,877

Preferred stock issuance
 
 
 
 
 
1,274

 
 
 
 
 
 
 
1,274

 
 
 
1,274

Treasury stock acquired in connection with share repurchases
 
 
 
 
 


 
 
 
(2,792
)
 
 
 
(2,792
)
 
 
 
(2,792
)
Stock-based compensation
 
 
 
 
 
90

 
 
 
 
 
 
 
90

 
 
 
90

Dividends on preferred stock
 
 
 
 
 
 
 
(84
)
 
 
 
 
 
(84
)
 
 
 
(84
)
Dividends on common stock
 
 
 
 
 
 
 
(1,263
)
 
 
 
 
 
(1,263
)
 
 
 
(1,263
)
Change in equity of noncontrolling interests
 
 
 
 
 
 
 
 
 
 
 
 
 

 
(20
)
 
(20
)
Net income (loss)
 
 
 
 
 
 
 
3,056

 
 
 
 
 
3,056

 
10

 
3,066

Other comprehensive income (loss), net of income tax
 
 
 
 
 
 
 
 
 
 
 
(7,339
)
 
(7,339
)
 

 
(7,339
)
Balance at September 30, 2018
 
$

 
$
12

 
$
32,475

 
$
27,331

 
$
(9,193
)
 
$
1,000

 
$
51,625

 
$
184

 
$
51,809

 
 
Preferred
Stock
 
Common
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Treasury
Stock
at Cost
 
Accumulated
Other
Comprehensive
Income (Loss)
 
Total
MetLife, Inc.’s
Stockholders’
Equity
 
Noncontrolling
Interests
 
Total
Equity
Balance at December 31, 2016, as previously reported
 
$

 
$
12

 
$
30,944

 
$
34,480

 
$
(3,474
)
 
$
5,347

 
$
67,309

 
$
171

 
$
67,480

Prior period revisions (Note 1)
 
 
 
 
 
 
 
203

 
 
 
19

 
222

 
 
 
222

Balance at December 31, 2016
 

 
12

 
30,944

 
34,683

 
(3,474
)
 
5,366

 
67,531

 
171

 
67,702

Treasury stock acquired in connection with share repurchases
 
 
 
 
 
 
 
 
 
(2,305
)
 
 
 
(2,305
)
 
 
 
(2,305
)
Stock-based compensation
 
 
 
 
 
122

 
 
 
 
 
 
 
122

 
 
 
122

Dividends on preferred stock
 
 
 
 
 
 
 
(58
)
 
 
 
 
 
(58
)
 
 
 
(58
)
Dividends on common stock
 
 
 
 
 
 
 
(1,295
)
 
 
 
 
 
(1,295
)
 
 
 
(1,295
)
Distribution of Brighthouse (Note 3)
 
 
 
 
 
 
 
(10,346
)
 
 
 
(1,320
)
 
(11,666
)
 
 
 
(11,666
)
Change in equity of noncontrolling interests
 
 
 
 
 
 
 
 
 
 
 
 
 

 
43

 
43

Net income (loss)
 
 
 
 
 
 
 
1,693

 
 
 
 
 
1,693

 
12

 
1,705

Other comprehensive income (loss), net of income tax
 
 
 
 
 
 
 
 
 
 
 
2,959

 
2,959

 
4

 
2,963

Balance at September 30, 2017
 
$

 
$
12

 
$
31,066

 
$
24,677

 
$
(5,779
)
 
$
7,005

 
$
56,981

 
$
230

 
$
57,211

See accompanying notes to the interim condensed consolidated financial statements.

5

MetLife, Inc.
Interim Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2018 and 2017 (Unaudited)
(In millions)

 
Nine Months
Ended
September 30,
 
2018
 
2017
Net cash provided by (used in) operating activities
$
10,437

 
$
10,233

Cash flows from investing activities
 
 
 
Sales, maturities and repayments of:
 
 
 
Fixed maturity securities available-for-sale
78,227

 
66,544

Equity securities
323

 
904

Mortgage loans
6,878

 
6,721

Real estate and real estate joint ventures
561

 
689

Other limited partnership interests
514

 
882

Purchases of:
 
 
 
Fixed maturity securities available-for-sale
(84,014
)
 
(76,010
)
Equity securities
(118
)
 
(705
)
Mortgage loans
(10,624
)
 
(9,988
)
Real estate and real estate joint ventures
(912
)
 
(1,078
)
Other limited partnership interests
(1,047
)
 
(1,064
)
Cash received in connection with freestanding derivatives
3,130

 
4,890

Cash paid in connection with freestanding derivatives
(3,745
)
 
(7,404
)
Cash disposed due to distribution of Brighthouse

 
(663
)
Purchases of businesses

 
(211
)
Net change in policy loans
(62
)
 
(16
)
Net change in short-term investments
(301
)
 
(209
)
Net change in other invested assets
174

 
(184
)
Other, net
24

 
(256
)
Net cash provided by (used in) investing activities
(10,992
)
 
(17,158
)
Cash flows from financing activities
 
 
 
Policyholder account balances:
 
 
 
Deposits
72,037

 
67,565

Withdrawals
(67,869
)
 
(62,233
)
Net change in payables for collateral under securities loaned and other transactions
719

 
2,316

Long-term debt issued
24

 
3,657

Long-term debt repaid
(1,311
)
 
(60
)
Collateral financing arrangements repaid
(48
)
 
(2,852
)
Distribution of Brighthouse

 
(2,793
)
Financing element on certain derivative instruments and other derivative related transactions, net
(15
)
 
(109
)
Treasury stock acquired in connection with share repurchases
(2,792
)
 
(2,305
)
Preferred stock issued, net of issuance costs
1,274

 

Dividends on preferred stock
(84
)
 
(58
)
Dividends on common stock
(1,263
)
 
(1,295
)
Other, net
(141
)
 
(144
)
Net cash provided by (used in) financing activities
531

 
1,689

Effect of change in foreign currency exchange rates on cash and cash equivalents balances
(187
)
 
382

Change in cash and cash equivalents
(211
)
 
(4,854
)
Cash and cash equivalents, beginning of period
12,701

 
17,877

Cash and cash equivalents, end of period
$
12,490

 
$
13,023

Cash and cash equivalents, of disposed subsidiary, beginning of period
$

 
$
5,226

Cash and cash equivalents, of disposed subsidiary, end of period
$

 
$

Cash and cash equivalents, from continuing operations, beginning of period
$
12,701

 
$
12,651

Cash and cash equivalents, from continuing operations, end of period
$
12,490

 
$
13,023

Supplemental disclosures of cash flow information
 
 
 
Net cash paid (received) for:
 
 
 
Interest
$
809

 
$
806

Income tax
$
695

 
$
633

Non-cash transactions:
 
 
 
Fixed maturity securities available-for-sale received in connection with pension risk transfer transaction
$
3,016

 
$

Brighthouse common stock exchange transaction (Note 3):
 
 
 
Reduction of long-term debt
$
944

 
$

Reduction of fair value option securities
$
1,030

 
$

Disposal of Brighthouse
 
 
 
Assets disposed
$

 
$
225,502

Liabilities disposed

 
(210,999
)
Net assets disposed
$

 
$
14,503

Cash disposed

 
(3,456
)
Net non-cash disposed
$

 
$
11,047

See accompanying notes to the interim condensed consolidated financial statements.

6

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited)


1. Business, Basis of Presentation and Summary of Significant Accounting Policies
Business
“MetLife” and the “Company” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. MetLife is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management. MetLife is organized into five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa (“EMEA”); and MetLife Holdings.
Basis of Presentation
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to adopt accounting policies and make estimates and assumptions that affect amounts reported on the interim condensed consolidated financial statements. In applying these policies and estimates, management makes subjective and complex judgments that frequently require assumptions about matters that are inherently uncertain. Many of these policies, estimates and related judgments are common in the insurance and financial services industries; others are specific to the Company’s business and operations. Actual results could differ from these estimates.
The accompanying interim condensed consolidated financial statements are unaudited and reflect all adjustments (including normal recurring adjustments) necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in conformity with GAAP. Interim results are not necessarily indicative of full year performance. The December 31, 2017 consolidated balance sheet data was derived from audited consolidated financial statements included in MetLife, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2017 (the “2017 Annual Report”), which include all disclosures required by GAAP. Therefore, these interim condensed consolidated financial statements should be read in conjunction with the consolidated financial statements of the Company included in the 2017 Annual Report.
Consolidation
The accompanying interim condensed consolidated financial statements include the accounts of MetLife, Inc. and its subsidiaries, as well as partnerships and joint ventures in which the Company has control, and variable interest entities (“VIEs”) for which the Company is the primary beneficiary. Intercompany accounts and transactions have been eliminated.
The Company uses the equity method of accounting for equity securities when it has significant influence or at least 20% interest and for real estate joint ventures and other limited partnership interests (“investees”) when it has more than a minor ownership interest or more than a minor influence over the investee’s operations. The Company generally recognizes its share of the investee’s earnings on a three-month lag in instances where the investee’s financial information is not sufficiently timely or when the investee’s reporting period differs from the Company’s reporting period. Subsequent to the adoption of guidance relating to the recognition and measurement of financial instruments on January 1, 2018, the Company accounts for interests in unconsolidated entities that are not accounted for under the equity method, at estimated fair value. Such investments were previously accounted for under the cost method of accounting. See “— Adoption of New Accounting Pronouncements.”
Discontinued Operations
The results of operations of a component of the Company that has either been disposed of or is classified as held-for-sale are reported in discontinued operations if certain criteria are met. A disposal of a component is reported in discontinued operations if the disposal represents a strategic shift that has or will have a major effect on the Company’s operations and financial results.
On August 4, 2017, MetLife, Inc. completed the separation of Brighthouse Financial, Inc. and its subsidiaries (“Brighthouse”) through a distribution of 96,776,670 shares of Brighthouse Financial, Inc. common stock to the MetLife, Inc. common shareholders (the “Separation”). The results of Brighthouse are reflected in MetLife, Inc.’s interim condensed consolidated financial statements as discontinued operations and, therefore, are presented as income (loss) from discontinued operations on the consolidated statements of operations and comprehensive income (loss). Intercompany transactions between the Company and Brighthouse prior to the Separation have been eliminated. Transactions between the Company and Brighthouse after the Separation are reflected in continuing operations for the Company. See Note 3 for information on discontinued operations and transactions with Brighthouse.

7

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Reclassifications
Certain amounts in the prior year periods’ interim condensed consolidated financial statements and related footnotes thereto have been reclassified to conform to the 2018 presentation as discussed throughout the Notes to the Interim Condensed Consolidated Financial Statements.
Revisions
As discussed in Note 1 of the Notes to the Consolidated Financial Statements included in the 2017 Annual Report, the Company made adjustments for group annuity reserves and assumed variable annuity guarantee reserves for which amounts previously reported have been immaterially restated. In addition, the Company has corrected other unrelated immaterial errors which were previously recorded in the periods the Company identified them.
A summary of the revisions to prior year periods’ net income (loss) available to MetLife, Inc.’s common shareholders is shown in the table below:
 
 
Three Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
 
2017
 
 
(In millions)
Assumed variable annuity guarantee reserves
 
$
67

 
$
128

Group annuity reserves
 
(12
)
 
(30
)
Other revisions to continuing operations, net
 
(71
)
 
(5
)
Impact to income (loss) from continuing operations before provision for income tax
 
(16
)
 
93

Provision for income tax expense (benefit)
 
(6
)
 
32

Impact to income (loss) from continuing operations, net of income tax
 
(10
)
 
61

Other revisions to discontinued operations, net of income tax
 

 
3

Impact to net income (loss) available to MetLife, Inc.’s common shareholders
 
$
(10
)
 
$
64


8

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

The impact of the revisions is shown in the tables below:
 
 
Three Months
Ended
September 30,
 
Nine Months
Ended
September 30,
 
 
2017
Interim Condensed Consolidated
Statements of Operations
and Comprehensive Income (Loss)
 
As
Previously
Reported
 
Revisions
 
As
Revised
 
As
Previously
Reported
 
Revisions
 
As
Revised
 
 
(In millions, except per share data)
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
Net investment gains (losses)
 
$
(606
)
 
$

 
$
(606
)
 
$
(439
)
 
$
25

 
$
(414
)
Net derivative gains (losses)
 
$
(190
)
 
$
67

 
$
(123
)
 
$
(663
)
 
$
128

 
$
(535
)
Total revenues
 
$
16,104

 
$
67

 
$
16,171

 
$
46,315

 
$
153

 
$
46,468

Expenses
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims
 
$
10,645

 
$
83

 
$
10,728

 
$
28,923

 
$
95

 
$
29,018

Other expenses
 
$
3,318

 
$

 
$
3,318

 
$
9,904

 
$
(35
)
 
$
9,869

Total expenses
 
$
15,603

 
$
83

 
$
15,686

 
$
43,833

 
$
60

 
$
43,893

Income (loss) from continuing operations before provision for income tax
 
$
501

 
$
(16
)
 
$
485

 
$
2,482

 
$
93

 
$
2,575

Provision for income tax expense (benefit)
 
$
(392
)
 
$
(6
)
 
$
(398
)
 
$
(148
)
 
$
32

 
$
(116
)
Income (loss) from continuing operations, net of income tax
 
$
893

 
$
(10
)
 
$
883

 
$
2,630

 
$
61

 
$
2,691

Income (loss) from discontinued operations, net of income tax
 
$
(968
)
 
$

 
$
(968
)
 
$
(989
)
 
$
3

 
$
(986
)
Net income (loss)
 
$
(75
)
 
$
(10
)
 
$
(85
)
 
$
1,641

 
$
64

 
$
1,705

Net income (loss) attributable to MetLife, Inc.
 
$
(81
)
 
$
(10
)
 
$
(91
)
 
$
1,629

 
$
64

 
$
1,693

Net income (loss) available to MetLife, Inc.’s common shareholders
 
$
(87
)
 
$
(10
)
 
$
(97
)
 
$
1,571

 
$
64

 
$
1,635

Comprehensive income (loss)
 
$
(182
)
 
$
(10
)
 
$
(192
)
 
$
4,623

 
$
45

 
$
4,668

Comprehensive income (loss) attributable to MetLife, Inc.
 
$
(192
)
 
$
(10
)
 
$
(202
)
 
$
4,607

 
$
45

 
$
4,652

Income (loss) from continuing operations, net of income tax, available to MetLife, Inc.’s common shareholders:
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
0.83

 
$
(0.01
)
 
$
0.82

 
$
2.38

 
$
0.06

 
$
2.44

Diluted
 
$
0.82

 
$
(0.01
)
 
$
0.81

 
$
2.36

 
$
0.06

 
$
2.42

Net income (loss) available to MetLife, Inc.’s common shareholders per common share:
 
 
 
 
 
 
 
 
 
 
 
 
Basic
 
$
(0.08
)
 
$
(0.01
)
 
$
(0.09
)
 
$
1.46

 
$
0.06

 
$
1.52

Diluted
 
$
(0.08
)
 
$
(0.01
)
 
$
(0.09
)
 
$
1.45

 
$
0.06

 
$
1.51


9

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Interim Condensed Consolidated Statements of Equity
 
As
Previously
Reported
 
Revisions
 
As
Revised
 
 
(In millions)
Retained Earnings
 
 
 
 
 
 
Balance at December 31, 2016
 
$
34,480

 
$
203

 
$
34,683

Net income (loss)
 
$
1,629

 
$
64

 
$
1,693

Balance at September 30, 2017
 
$
24,410

 
$
267

 
$
24,677

Accumulated Other Comprehensive Income (Loss)
 
 
 
 
 
 
Balance at December 31, 2016
 
$
5,347

 
$
19

 
$
5,366

Other comprehensive income (loss), net of income tax
 
$
2,978

 
$
(19
)
 
$
2,959

Balance at September 30, 2017
 
$
7,005

 
$

 
$
7,005

Total MetLife, Inc.’s Stockholders’ Equity
 
 
 
 
 
 
Balance at December 31, 2016
 
$
67,309

 
$
222

 
$
67,531

Balance at September 30, 2017
 
$
56,714

 
$
267

 
$
56,981

Total Equity
 
 
 
 
 
 
Balance at December 31, 2016
 
$
67,480

 
$
222

 
$
67,702

Balance at September 30, 2017
 
$
56,944

 
$
267

 
$
57,211

Adoption of New Accounting Pronouncements
Effective January 1, 2018, the Company early adopted guidance relating to income taxes. The new guidance was applied in the period of adoption. Current GAAP guidance requires that the effect of a change in tax laws or rates on deferred tax liabilities or assets to be included in income from continuing operations in the reporting period that includes the enactment date, even if the related income tax effects were originally charged or credited directly to accumulated other comprehensive income (“AOCI”). The Company’s accounting policy for the release of stranded tax effects in AOCI is on an aggregate portfolio basis. The new guidance allows a reclassification of AOCI to retained earnings for stranded tax effects resulting from the Tax Cuts and Jobs Act of 2017 (“U.S. Tax Reform”). Due to U.S. Tax Reform and the change in corporate tax rates, at December 22, 2017, the Company reported stranded tax effects in AOCI related to unrealized gains and losses on available-for-sale (“AFS”) securities, cumulative foreign translation adjustments and deferred costs on pension benefit plans. With the adoption of the guidance, the Company released these stranded tax effects in AOCI resulting in a decrease to retained earnings as of January 1, 2018 of $1.2 billion with a corresponding increase to AOCI.
Effective January 1, 2018, the Company prospectively adopted guidance relating to stock compensation. The new guidance includes guidance on determining which changes to the terms and conditions of share-based payment awards require an entity to apply modification accounting under Accounting Standards Codification (“ASC”) Topic 718, Compensation - Stock Compensation. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Effective January 1, 2018 the Company retrospectively adopted guidance on the presentation of net periodic pension cost and net periodic postretirement benefit cost. The new guidance requires that an employer that offers to its employees defined benefit pension or other postretirement benefit plans report the service cost component in the same line item or items as other compensation costs. The other components of net periodic benefit cost are required to be presented in the income statement separately from the service cost component and outside a subtotal of income from operations, if one is presented. If a separate line item is not used, the line item used in the income statement to present the other components of net periodic benefit cost must be disclosed. In addition, the guidance allows only the service cost component to be eligible for capitalization when applicable. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Effective January 1, 2018, the Company adopted, using a modified retrospective approach, guidance relating to de-recognition of nonfinancial assets. The new guidance clarifies the scope and accounting of a financial asset that meets the definition of an “in-substance nonfinancial asset” and defines the term, “in-substance nonfinancial asset.” The new guidance also adds guidance for partial sales of nonfinancial assets. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.

10

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Effective January 1, 2018, the Company retrospectively adopted guidance relating to restricted cash. The new guidance requires that a statement of cash flows explain the change during the period in the total of cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents. As a result, the new guidance requires that amounts generally described as restricted cash and restricted cash equivalents should be included with cash and cash equivalents when reconciling the beginning-of-period and end-of-period total amounts shown on the statement of cash flows. The new guidance does not provide a definition of restricted cash or restricted cash equivalents. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Effective January 1, 2018, the Company adopted, using a modified retrospective approach, guidance relating to tax accounting for intra-entity transfers of assets. Prior guidance prohibited the recognition of current and deferred income taxes for an intra-entity asset transfer until the asset has been sold to an outside party. The new guidance requires an entity to recognize the income tax consequences of an intra-entity transfer of an asset other than inventory when the transfer occurs. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Effective January 1, 2018, the Company retrospectively adopted guidance relating to cash flow statement presentation. The new guidance addresses diversity in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
Effective January 1, 2018, the Company adopted, using a modified retrospective approach, guidance relating to recognition and measurement of financial instruments. The guidance changes the current accounting guidance related to (i) the classification and measurement of certain equity investments, (ii) the presentation of changes in the fair value of financial liabilities measured under the fair value option (“FVO”) that are due to instrument-specific credit risk, and (iii) certain disclosures associated with the fair value of financial instruments. Effective January 1, 2018, there will no longer be a requirement to assess equity securities for impairment since such securities will be measured at fair value through net income. Additionally, there will no longer be a requirement to assess equity securities for embedded derivatives requiring bifurcation. The adoption of this guidance resulted in a $328 million, net of income tax, increase to retained earnings largely offset by a decrease to AOCI that was primarily attributable to $1.7 billion of equity securities previously classified and measured as equity securities AFS. At December 31, 2017, equity securities of $16.0 billion primarily associated with contractholder-directed investments are accounted for using the FVO and therefore were unaffected by the new guidance. The Company has included the required disclosures related to equity securities within Note 6.
Effective January 1, 2018, the Company adopted, using a modified retrospective approach, guidance relating to revenue recognition. The new guidance supersedes nearly all existing revenue recognition guidance under U.S. GAAP. However, it does not impact the accounting for insurance and investment contracts within the scope of ASC Topic 944, Financial Services - Insurance, leases, financial instruments and certain guarantees. For those contracts that are impacted, the new guidance requires an entity to recognize revenue upon the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled, in exchange for those goods or services. The adoption of the guidance did not have a material impact on the Company’s consolidated financial statements.
For the three months and nine months ended September 30, 2018, the Company identified $329 million and $979 million, respectively, of revenue streams within the scope of the guidance that are all included within other revenues on the interim condensed consolidated statements of operations and comprehensive income (loss). Such amounts primarily consisted of: (i) prepaid legal plans and administrative-only contracts within the U.S. segment of $127 million and $382 million for the three months and nine months ended September 30, 2018, respectively, (ii) distribution and administrative services fees within the MetLife Holdings segment of $56 million and $170 million for the three months and nine months ended September 30, 2018, respectively, and (iii) fee-based investment management services within Corporate & Other of $74 million and $219 million for the three months and nine months ended September 30, 2018, respectively.
Substantially all of the revenue from these services is recognized over time as the applicable services are provided or are made available to the customers and control is transferred continuously. The consideration received for these services is variable and constrained to the amount not probable of a significant revenue reversal.

11

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

Other
Effective January 16, 2018, the London Clearing House (“LCH”) amended its rulebook, resulting in the characterization of variation margin transfers as settlement payments, as opposed to adjustments to collateral. These amendments impacted the accounting treatment of the Company’s centrally cleared derivatives, for which the LCH serves as the central clearing party. As of the effective date, the application of the amended rulebook reduced gross derivative assets by $369 million, gross derivative liabilities by $203 million, accrued investment income by $14 million, collateral receivables recorded within premiums, reinsurance and other receivables by $184 million, and collateral payables recorded within payables for collateral under securities loaned and other transactions by $365 million. The application of the amended rulebook increased accrued investment expense recorded within other liabilities by $1 million.
Future Adoption of New Accounting Pronouncements
In October 2018, the Financial Accounting Standards Board (“FASB”) issued new guidance on consolidation (Accounting Standards Update (“ASU”) 2018-17, Consolidation (Topic 810): Targeted Improvements to Related Party Guidance for Variable Interest Entities). The new guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years and should be applied retrospectively with a cumulative effect adjustment to retained earnings at the beginning of the earliest period presented. Early adoption is permitted. The new guidance provides that indirect interests held through related parties in common control arrangements should be considered on a proportional basis for determining whether fees paid to decisionmakers and service providers are variable interests. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In October 2018, the FASB issued new guidance regarding derivatives (ASU 2018-16, Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (SOFR) Overnight Index Swap (OIS) Rate as a Benchmark Interest Rate for Hedge Accounting Purposes). The new guidance is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years and should be applied prospectively for qualifying new or redesignated hedging relationships entered into after January 1, 2019. The amendments permit the use of the overnight index swap rate based on the Secured Overnight Financing Rate to be used as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In August 2018, the FASB issued new guidance on implementation costs in a cloud computing arrangement that is a service contract (ASU 2018-15, Intangibles—Goodwill and Other—Internal-Use Software: Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract). The new guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The new guidance can be applied either prospectively to eligible costs incurred on or after the guidance is first applied, or retrospectively to all periods presented. The new guidance requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance to determine which implementation costs to capitalize as assets. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In August 2018, the FASB issued new guidance on defined benefit pension or other postretirement plans (ASU 2018-14, Compensation—Retirement Benefits—Defined Benefit Plans—General (Subtopic 715-20): Disclosure Framework—Changes to the Disclosure Requirements for Defined Benefit Plans). The new guidance is effective for fiscal years ending after December 15, 2020. Early adoption is permitted. The new guidance should be applied on a retrospective basis to all periods presented. The new guidance modifies and clarifies certain disclosure requirements. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In August 2018, the FASB issued new guidance on fair value measurement (ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement). The new guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The guidance modifies the disclosure requirements on fair value by removing some requirements, modifying others, adding changes in unrealized gains and losses included in other comprehensive income (loss) (“OCI”) for recurring Level 3 fair value measurements, and providing the option to disclose certain other quantitative information with respect to significant unobservable inputs in lieu of a weighted average. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

12

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

In August 2018, the FASB issued new guidance on long-duration insurance contracts (ASU 2018-12, Financial Services—Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts). The new guidance is effective for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years, with required retrospective application to January 1, 2019. Early adoption is permitted. The new guidance (i) prescribes the discount rate to be used in measuring the liability for future policy benefits for traditional and limited payment long-duration contracts, and requires assumptions for those liability valuations to be updated after contract inception, (ii) requires more market-based product guarantees on certain separate account and other account balance long-duration contracts to be accounted for at fair value, (iii) simplifies the amortization of deferred policy acquisition costs (“DAC”) for virtually all long-duration contracts, and (iv) introduces certain financial statement presentation requirements, as well as significant additional quantitative and qualitative disclosures. The Company has just begun its implementation efforts and is currently evaluating the impact of the new guidance. Given the nature and extent of the required changes to a significant portion of the Company’s operations, the adoption of this standard is expected to have a material impact on the consolidated financial statements.
In August 2017, the FASB issued new guidance on hedging activities (ASU 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities). The new guidance is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years and should be applied on a modified retrospective basis through a cumulative effect adjustment to retained earnings. Early adoption is permitted. The new guidance simplifies the application of hedge accounting in certain situations and amends the hedge accounting model to enable entities to better portray the economics of their risk management activities in their financial statements. Upon the adoption of ASU 2017-12, the Company will make certain changes to its assessment of hedge effectiveness for fair value hedging relationships, and the Company will also reclassify hedge ineffectiveness for cash flow hedging relationships existing as of the adoption date, which was previously recorded to earnings, to AOCI. The estimated impact of adoption is a decrease to retained earnings of approximately $100 million to $250 million.
In March 2017, the FASB issued new guidance on purchased callable debt securities (ASU 2017-08, Receivables—Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities). The new guidance is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years and should be applied on a modified retrospective basis through a cumulative effect adjustment to retained earnings. Early adoption is permitted. The ASU shortens the amortization period for certain callable debt securities held at a premium and requires the premium to be amortized to the earliest call date. However, the new guidance does not require an accounting change for securities held at a discount whose discount continues to be amortized to maturity. The Company does not expect the adoption to have a material impact on its consolidated financial statements.
In January 2017, the FASB issued new guidance on goodwill impairment (ASU 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment). The new guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years, and should be applied on a prospective basis. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The new guidance simplifies the current two-step goodwill impairment test by eliminating Step 2 of the test. See Note 11 of the Notes to the Consolidated Financial Statements included in the 2017 Annual Report for a description of the two-step test. The new guidance requires a one-step impairment test in which an entity compares the fair value of a reporting unit with its carrying amount and recognizes an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value, if any. The Company expects the adoption of this new guidance will reduce the complexity involved with the evaluation of goodwill for impairment. The impact of the new guidance will depend on the outcomes of future goodwill impairment tests.

13

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
1. Business, Basis of Presentation and Summary of Significant Accounting Policies (continued)

In June 2016, the FASB issued new guidance on measurement of credit losses on financial instruments (ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments). The new guidance is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years. For substantially all financial assets, the ASU should be applied on a modified retrospective basis through a cumulative effect adjustment to retained earnings. For previously impaired debt securities and certain debt securities acquired with evidence of credit quality deterioration since origination, the new guidance should be applied prospectively. Early adoption is permitted for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. This ASU replaces the incurred loss impairment methodology with one that reflects expected credit losses. The measurement of expected credit losses should be based on historical loss information, current conditions, and reasonable and supportable forecasts. The new guidance requires that an other-than-temporary impairment (“OTTI”) on a debt security will be recognized as an allowance going forward, such that improvements in expected future cash flows after an impairment will no longer be reflected as a prospective yield adjustment through net investment income, but rather a reversal of the previous impairment and recognized through realized investment gains and losses. The guidance also requires enhanced disclosures. The Company has assessed the asset classes impacted by the new guidance and is currently assessing the accounting and reporting system changes that will be required to comply with the new guidance. The Company believes that the most significant impact upon adoption will be to its mortgage loan investments. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.
In February 2016, the FASB issued new guidance on leasing transactions (ASU 2016-02, Leases (Topic 842)). The new guidance is effective for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The new guidance requires a lessee to recognize assets and liabilities for leases with lease terms of more than 12 months. Leases would be classified as finance or operating leases and both types of leases will be recognized on the balance sheet. Lessor accounting will remain largely unchanged from current guidance except for certain targeted changes. The new guidance will also require new qualitative and quantitative disclosures. In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases, amending certain aspects of the new leases standard. Also in July 2018, the FASB issued ASU 2018-11, Leases (Topic 842): Targeted Improvements, which provides lessors with a practical expedient not to separate lease and non-lease components for certain operating leases and with an additional transition method.
The Company will adopt the new guidance under ASU 2016-02 and related amendments on January 1, 2019 and expects to elect certain practical expedients permitted under the transition guidance. In addition, the Company expects to elect the transition option, which allows the Company to use the modified retrospective transition method and recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption but does not require restatement of prior periods. The Company has developed an integrated implementation plan and formed a multi-functional working group with a project governance structure to address any resource, system, data and process gaps related to the implementation of the new standard. The Company is currently in the process of integrating a lease accounting technology solution and developing updated reporting processes and internal controls to facilitate compliance with the new guidance.
While the Company is in the process of evaluating the impact of this guidance on its consolidated financial statements, the Company believes the most significant changes relate to (i) the recognition of new right of use assets and lease liabilities on the consolidated balance sheet for real estate operating leases; and (ii) the recognition of deferred gains associated with previous sale-leaseback transactions as a cumulative effect adjustment to retained earnings. On adoption, the Company expects to recognize additional operating liabilities, with corresponding right of use assets of the same amount adjusted for prepaid/deferred rent, unamortized initial direct costs and potential impairment of right of use assets based on the present value of the remaining minimum rental payments. These assets and liabilities are expected to represent less than 1% of the Company’s total assets and total liabilities, and the Company does not expect the adoption to have a material impact on its consolidated financial statements.
2. Segment Information
MetLife is organized into five segments: U.S.; Asia; Latin America; EMEA; and MetLife Holdings. In addition, the Company reports certain of its results of operations in Corporate & Other.

14

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
2. Segment Information (continued)

U.S.
The U.S. segment offers a broad range of protection products and services aimed at serving the financial needs of customers throughout their lives. These products are sold to corporations and their respective employees, other institutions and their respective members, as well as individuals. The U.S. segment is organized into three businesses: Group Benefits, Retirement and Income Solutions (“RIS”) and Property & Casualty.
The Group Benefits business offers insurance products and services which include life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision and accident & health coverages, as well as prepaid legal plans. This business also sells administrative services-only arrangements to some employers.
The RIS business offers a broad range of annuity and investment products, including stable value and pension risk transfer products, institutional income annuities, tort settlements, capital market investment products, as well as postretirement benefits and company-, bank- or trust-owned life insurance.
The Property & Casualty business offers personal and commercial lines of property and casualty insurance, including private passenger automobile, homeowners’ and personal excess liability insurance. In addition, Property & Casualty offers small business owners property, liability and business interruption insurance.
Asia
The Asia segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include whole and term life, endowments, universal and variable life, accident & health insurance and fixed and variable annuities.
Latin America
The Latin America segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, retirement and savings products, accident & health insurance and credit insurance.
EMEA
The EMEA segment offers a broad range of products to both individuals and corporations, as well as other institutions and their respective employees, which include life insurance, accident & health insurance, retirement and savings products and credit insurance.
MetLife Holdings
The MetLife Holdings segment consists of operations relating to products and businesses no longer actively marketed by the Company in the United States, such as variable, universal, term and whole life insurance, variable, fixed and index-linked annuities, long-term care insurance, as well as the assumed variable annuity guarantees from the Company’s former operating joint venture in Japan.
Corporate & Other
Corporate & Other contains the excess capital, as well as certain charges and activities, not allocated to the segments, including external integration and disposition costs, internal resource costs for associates committed to acquisitions and dispositions, enterprise-wide strategic initiative restructuring charges and various start-up businesses (including the investment management business through which the Company offers fee-based investment management services to institutional clients). Additionally, Corporate & Other includes run-off businesses such as the direct to consumer portion of the U.S. Direct business. Corporate & Other also includes interest expense related to the majority of the Company’s outstanding debt, as well as expenses associated with certain legal proceedings and income tax audit issues. In addition, Corporate & Other includes the elimination of intersegment amounts, which generally relate to affiliated reinsurance and intersegment loans, which bear interest rates commensurate with related borrowings.

15

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
2. Segment Information (continued)

Financial Measures and Segment Accounting Policies
Adjusted earnings is used by management to evaluate performance and allocate resources. Consistent with GAAP guidance for segment reporting, adjusted earnings is also the Company’s GAAP measure of segment performance and is reported below. Adjusted earnings should not be viewed as a substitute for income (loss) from continuing operations, net of income tax. The Company believes the presentation of adjusted earnings, as the Company measures it for management purposes, enhances the understanding of its performance by highlighting the results of operations and the underlying profitability drivers of the business.
Adjusted earnings is defined as adjusted revenues less adjusted expenses, net of income tax.
The financial measures of adjusted revenues and adjusted expenses focus on the Company’s primary businesses principally by excluding the impact of market volatility, which could distort trends, and revenues and costs related to non-core products and certain entities required to be consolidated under GAAP. Also, these measures exclude results of discontinued operations under GAAP and other businesses that have been or will be sold or exited by MetLife but do not meet the discontinued operations criteria under GAAP and are referred to as divested businesses. Divested businesses also includes the net impact of transactions with exited businesses that have been eliminated in consolidation under GAAP and costs relating to businesses that have been or will be sold or exited by MetLife that do not meet the criteria to be included in results of discontinued operations under GAAP. Adjusted revenues also excludes net investment gains (losses) and net derivative gains (losses). Adjusted expenses also excludes goodwill impairments.
The following additional adjustments are made to revenues, in the line items indicated, in calculating adjusted revenues:
Universal life and investment-type product policy fees excludes the amortization of unearned revenue related to net investment gains (losses) and net derivative gains (losses) and certain variable annuity guaranteed minimum income benefits (“GMIBs”) fees (“GMIB fees”);
Net investment income: (i) includes earned income on derivatives and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment, (ii) excludes post-tax adjusted earnings adjustments relating to insurance joint ventures accounted for under the equity method, (iii) excludes certain amounts related to contractholder-directed unit-linked investments, (iv) excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP and (v) includes distributions of profits from certain other limited partnership interests that were previously accounted for under the cost method, but are now accounted for at estimated fair value, where the change in estimated fair value is recognized in net investment gains (losses) for GAAP; and
Other revenues is adjusted for settlements of foreign currency earnings hedges and excludes fees received in association with services provided under transition service agreements (“TSA fees”).

16

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
2. Segment Information (continued)

The following additional adjustments are made to expenses, in the line items indicated, in calculating adjusted expenses:
Policyholder benefits and claims and policyholder dividends excludes: (i) changes in the policyholder dividend obligation related to net investment gains (losses) and net derivative gains (losses), (ii) inflation-indexed benefit adjustments associated with contracts backed by inflation-indexed investments and amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and other pass-through adjustments, (iii) benefits and hedging costs related to GMIBs (“GMIB costs”) and (iv) market value adjustments associated with surrenders or terminations of contracts (“Market value adjustments”);
Interest credited to policyholder account balances includes adjustments for earned income on derivatives and amortization of premium on derivatives that are hedges of policyholder account balances but do not qualify for hedge accounting treatment and excludes amounts related to net investment income earned on contractholder-directed unit-linked investments;
Amortization of DAC and value of business acquired (“VOBA”) excludes amounts related to: (i) net investment gains (losses) and net derivative gains (losses), (ii) GMIB fees and GMIB costs and (iii) Market value adjustments;
Amortization of negative VOBA excludes amounts related to Market value adjustments;
Interest expense on debt excludes certain amounts related to securitization entities that are VIEs consolidated under GAAP; and
Other expenses excludes costs related to: (i) noncontrolling interests, (ii) implementation of new insurance regulatory requirements and (iii) acquisition, integration and other costs. Other expenses includes TSA fees.
Adjusted earnings also excludes the recognition of certain contingent assets and liabilities that could not be recognized at acquisition or adjusted for during the measurement period under GAAP business combination accounting guidance.
The tax impact of the adjustments mentioned above are calculated net of the U.S. or foreign statutory tax rate, which could differ from the Company’s effective tax rate. Additionally, the provision for income tax (expense) benefit also includes the impact related to the timing of certain tax credits, as well as certain tax reforms.
Set forth in the tables below is certain financial information with respect to the Company’s segments, as well as Corporate & Other, for the three months and nine months ended September 30, 2018 and 2017. The segment accounting policies are the same as those used to prepare the Company’s consolidated financial statements, except for adjusted earnings adjustments as defined above. In addition, segment accounting policies include the method of capital allocation described below.
Economic capital is an internally developed risk capital model, the purpose of which is to measure the risk in the business and to provide a basis upon which capital is deployed. The economic capital model accounts for the unique and specific nature of the risks inherent in the Company’s business.
The Company’s economic capital model, coupled with considerations of local capital requirements, aligns segment allocated equity with emerging standards and consistent risk principles. The model applies statistics-based risk evaluation principles to the material risks to which the Company is exposed. These consistent risk principles include calibrating required economic capital shock factors to a specific confidence level and time horizon while applying an industry standard method for the inclusion of diversification benefits among risk types. The Company’s management is responsible for the ongoing production and enhancement of the economic capital model and reviews its approach periodically to ensure that it remains consistent with emerging industry practice standards.
Segment net investment income is credited or charged based on the level of allocated equity; however, changes in allocated equity do not impact the Company’s consolidated net investment income, income (loss) from continuing operations, net of income tax, or adjusted earnings.
Net investment income is based upon the actual results of each segment’s specifically identifiable investment portfolios adjusted for allocated equity. Other costs are allocated to each of the segments based upon: (i) a review of the nature of such costs; (ii) time studies analyzing the amount of employee compensation costs incurred by each segment; and (iii) cost estimates included in the Company’s product pricing.

17

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
2. Segment Information (continued)

 
 
 
 
 
 
 
Three Months Ended September 30, 2018
 
U.S.
 
Asia
 
Latin
America
 
EMEA
 
MetLife
Holdings
 
Corporate
& Other
 
Total
 
Adjustments
 
Total
Consolidated
 
 
(In millions)
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
6,431

 
$
1,689

 
$
692

 
$
514

 
$
949

 
$
(33
)
 
$
10,242

 
$

 
$
10,242

Universal life and investment-type product policy fees
 
252

 
428

 
229

 
105

 
286

 

 
1,300

 
43

 
1,343

Net investment income
 
1,787

 
830

 
339

 
73

 
1,375

 
58

 
4,462

 
24

 
4,486

Other revenues
 
206

 
12

 
7

 
15

 
70

 
86

 
396

 
83

 
479

Net investment gains (losses)
 

 

 

 

 

 

 

 
117

 
117

Net derivative gains (losses)
 

 

 

 

 

 

 

 
(378
)
 
(378
)
Total revenues
 
8,676

 
2,959

 
1,267

 
707

 
2,680

 
111

 
16,400

 
(111
)
 
16,289

Expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Policyholder benefits and claims and policyholder dividends
 
6,219

 
1,354

 
670

 
281

 
1,766

 
(38
)
 
10,252

 
155

 
10,407

Interest credited to policyholder account balances
 
457

 
381

 
102

 
24

 
238

 

 
1,202

 
132

 
1,334

Capitalization of DAC
 
(116
)
 
(478
)
 
(97
)
 
(109
)
 
(8
)
 
(2
)
 
(810
)
 

 
(810
)
Amortization of DAC and VOBA
 
128

 
366

 
5

 
110

 
13

 
2

 
624

 
108

 
732

Amortization of negative VOBA
 

 
(4
)
 
(1
)
 
(2
)
 

 

 
(7
)
 

 
(7
)
Interest expense on debt
 
2

 

 
2

 

 
2

 
246

 
252

 
15

 
267

Other expenses
 
982

 
943

 
351

 
333

 
264

 
314

 
3,187

 
100

 
3,287

Total expenses
 
7,672

 
2,562

 
1,032

 
637

 
2,275

 
522

 
14,700

 
510

 
15,210

Provision for income tax expense (benefit)
 
209

 
131

 
65

 
15

 
78

 
(206
)
 
292

 
(128
)
 
164

Adjusted earnings
 
$
795

 
$
266

 
$
170

 
$
55

 
$
327

 
$
(205
)
 
1,408

 
 
 
 
Adjustments to:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
(111
)
 
 
 
 
Total expenses
 
 
 
 
 
 
 
 
 
 
 
 
 
(510
)
 
 
 
 
Provision for income tax (expense) benefit
 
 
 
 
 
 
 
 
 
 
 
 
 
128

 
 
 
 
Income (loss) from continuing operations, net of income tax
 
 
 
 
 
 
 
 
 
 
 
 
 
$
915

 
 
 
$
915


18

MetLife, Inc.
Notes to the Interim Condensed Consolidated Financial Statements (Unaudited) — (continued)
2. Segment Information (continued)

 
 
 
 
 
 
 
Three Months Ended September 30, 2017
 
U.S.
 
Asia
 
Latin
America
 
EMEA
 
MetLife
Holdings
 
Corporate
& Other
 
Total
 
Adjustments
 
Total
Consolidated
 
 
(In millions)
Revenues
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Premiums
 
$
6,987

 
$
1,696

 
$
701

 
$
527

 
$
989

 
$
13

 
$
10,913

 
$
(37
)
 
$
10,876

Universal life and investment-type product policy fees
 
247

 
458

 
229

 
109

 
349

 

 
1,392

 
36

 
1,428

Net investment income
 
1,602

 
762

 
299

 
77

 
1,390

 
26

 
4,156

 
139

 
4,295

Other revenues
 
197

 
11

 
7

 
(2
)
 
37

 
65

 
315

 
(14
)
 
301

Net investment gains (losses)
 

 

 

 

 

 

 

 
(606
)
 
(606
)
Net derivative gains (losses)
 

 

 

 

 

 

 

 
(123
)
 
(123
)
Total revenues
 
9,033

 
2,927

 
1,236

 
711

 
2,765